Innovative In-vitro Diagnostic (IVD) Kit: SeveriDx
Novel prognostic biomarker enabling
early detection of acute respiratory infection risks
Identifies high-risk respiratory conditions using a universal prognostic biomarker.
- Collects samples easily with non-invasive nasal swabs
- Seamlessly integrates into clinical and diagnostic labs
- Utilizes well-established technology compatible with existing lab settings
- Delivers rapid results in just 90 minutes
- Adaptable for both point-of-care and lab settings
Benefits
Physicians and clinics
- Guiding precise treatment decisions, and understanding patient health.
- Highlighting high-risk individuals, a prognostic biomarker of future health issues.
- Navigating therapy, monitoring treatment.
- Easy and accessible non-invasive materials.
Diagnostics and clinical labs
- Easy-to-use method with existing instrumentation in labs
- Well-established PCR technology
- Stable and non-infectious material
- Compatible with all PCR platforms
- POC testing and laboratory mode
Hospital management
- Bed occupancy management
- Patient stratification for hospitalization
- Saving money due to an effective treatment
- Cheap and fast analysis
- Enhancing operational efficiency
- Prioritizing care delivery
Basic life science researches
- Creating groundbreaking medications tailored to meet the specific
needs of patients. - Diverse applications are used in the development of products for diagnostic and research purposes.
Government insurance companies
- Improving medical care
- Better decision-making process in stratification of patients for hospitalization
- Contribution to cost savings and enhancements in healthcare quality.
Applications
The SeveriDx is based on a novel universal biomarker that helps identify individuals at high risk of developing severe health complications from any respiratory infection. It provides a comprehensive framework for determining the most appropriate treatment strategies in conjunction with established risk factors such as CRP.
SeveriDx allows for timely recognition of a rapidly progressive immune response, providing a great opportunity to prevent the development of serious clinical conditions. Moreover, SeveriDx offers the possibility of stratifying patient groups with mild and serious health issues at general medical practitioners or in emergencies, identifying individuals at risk for further monitoring.“
Laboratory Testing
- SeveriDx is an RT-qPCR test, whether statim or regular, that can function as a stand-alone test or be used in a multiplex with infectious pathogens.
- SeveriDx, next to CRP (bacterial/viral), provides information about the severity of infectious diseases.
- SeveriDx and CRP together form a powerful diagnostic duo, guiding more precise treatment decisions.
Point-of-care (POC) testing
- The POC tests are available for use in general practitioners’ offices, emergency departments, and hospital labs.
- In general medical practices, POC testing serves as a red flag, triggering additional medical evaluation.